PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER...

26

Transcript of PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER...

Page 1: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 2: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 3: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 4: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 5: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 6: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 7: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 8: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 9: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 10: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 11: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 12: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 13: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 14: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 15: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 16: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 17: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 18: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 19: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 20: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 21: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 22: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 23: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 24: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 25: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms
Page 26: PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/411... · treatment Perrigg IT NER OLDREž ACO Cold & flu/ General heath PHYSIOMER Natural decongestant PHYTOSUN aroms

Deutsche Bank Healthcare Conferencefilecache.investorroom.com/mr5ir_perrigo/132...Quality, Affordable Healthcare Products. Consumer Healthcare Segment. The Leader in Rx to OTC switches.

Deutsche Bank Healthcare Conferencefilecache.investorroom.com/mr5ir_perrigo/132...Quality, Affordable Healthcare Products. Consumer Healthcare Segment. The Leader in Rx to OTC switches.

Directors’ Report and Consolidated Financial Statements ...filecache.investorroom.com/mr5ir_perrigo/416/download/Perrigo 201… · Perrigo Company plc Directors’ Report and Consolidated

Directors’ Report and Consolidated Financial Statements ...filecache.investorroom.com/mr5ir_perrigo/416/download/Perrigo 201… · Perrigo Company plc Directors’ Report and Consolidated

Perrigo 2016 Third Quarter Financial Resultsfilecache.investorroom.com/mr5ir_perrigo/443/download...OTC delivers greater healthcare efficiency and value Store brand proposition further

Perrigo 2016 Third Quarter Financial Resultsfilecache.investorroom.com/mr5ir_perrigo/443/download...OTC delivers greater healthcare efficiency and value Store brand proposition further

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/491/download/Q3 Earning… · Perri o Total Cash as of 9/30/2017 $776 Million See Attached Appendix reconciliation

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/491/download/Q3 Earning… · Perri o Total Cash as of 9/30/2017 $776 Million See Attached Appendix reconciliation

Diptic Pack Stop Celulit - Aroms Natur · DE GORDURA. ELIMINA Y DRENA LA GRASA MOVILIZADA. E E A GORDURA MOBILIZADA. e de la anja. e-se da anja ... **Esteres de aceite de palma que

Diptic Pack Stop Celulit - Aroms Natur · DE GORDURA. ELIMINA Y DRENA LA GRASA MOVILIZADA. E E A GORDURA MOBILIZADA. e de la anja. e-se da anja ... **Esteres de aceite de palma que

Perrigo Fiscal 2014 First Quarter Conference Callfilecache.investorroom.com/mr5ir_perrigo/268/download...Q1 2014 Q1 2013 Change 38 2%38.2% 37 1%37.1% 110 bps110 bps Operating Margin*

Perrigo Fiscal 2014 First Quarter Conference Callfilecache.investorroom.com/mr5ir_perrigo/268/download...Q1 2014 Q1 2013 Change 38 2%38.2% 37 1%37.1% 110 bps110 bps Operating Margin*

ADRF Duo-i6525 User Manual - Powerful Signalpowerfulsignal.com/content/adrf-duo-i6525-manual.pdf · AROMS ADRF Repeater Operation and Management System BTS Base Transceiver Station

ADRF Duo-i6525 User Manual - Powerful Signalpowerfulsignal.com/content/adrf-duo-i6525-manual.pdf · AROMS ADRF Repeater Operation and Management System BTS Base Transceiver Station

Perrigofilecache.investorroom.com/mr5ir_perrigo/383/download...3 Deal Overview Perrigo will acquire a number of leading brands from GSK, which generated net sales of ~$110 million(1)

Perrigofilecache.investorroom.com/mr5ir_perrigo/383/download...3 Deal Overview Perrigo will acquire a number of leading brands from GSK, which generated net sales of ~$110 million(1)

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/485/download... · 2017-06-20 · June 20, 2017 . Forward — Looking ... projections are reasonable, such forward-looking

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/485/download... · 2017-06-20 · June 20, 2017 . Forward — Looking ... projections are reasonable, such forward-looking

2018 Annual Reportfilecache.investorroom.com/mr5ir_perrigo/546... · Perrigo Company plc is ... Perrigo 2018 Annual Report. Perrigo 2018 Annual Report | 3 Inside 04 KEY FACTS 05 2018

2018 Annual Reportfilecache.investorroom.com/mr5ir_perrigo/546... · Perrigo Company plc is ... Perrigo 2018 Annual Report. Perrigo 2018 Annual Report | 3 Inside 04 KEY FACTS 05 2018

2010 515 Eastern Avenue Allegan, Michigan 49010 (269) 673 ...filecache.investorroom.com/mr5ir_perrigo/159... · NASDAQ Global Select Market® and the Tel Aviv Stock Exchange (TASE)

2010 515 Eastern Avenue Allegan, Michigan 49010 (269) 673 ...filecache.investorroom.com/mr5ir_perrigo/159... · NASDAQ Global Select Market® and the Tel Aviv Stock Exchange (TASE)

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/492/download/Q3... · 2017. 11. 14. · Q3 2017 Financial Information Q3 2017 Reported $1 ,231 $498 38 288 $162 34

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/492/download/Q3... · 2017. 11. 14. · Q3 2017 Financial Information Q3 2017 Reported $1 ,231 $498 38 288 $162 34

2018 J.P. Morgan Healthcare Conference January 9, 2018filecache.investorroom.com/mr5ir_perrigo/494/download/18... · 2018. 1. 9. · Full year effect of successful 2017 new product

2018 J.P. Morgan Healthcare Conference January 9, 2018filecache.investorroom.com/mr5ir_perrigo/494/download/18... · 2018. 1. 9. · Full year effect of successful 2017 new product

web.mit.eduweb.mit.edu/ceder/publications/Document 47.pdf · possible rearrangements of, say, two types of aroms,A and B, on the sites of a parent lattice, fcc or bcc, for example,

web.mit.eduweb.mit.edu/ceder/publications/Document 47.pdf · possible rearrangements of, say, two types of aroms,A and B, on the sites of a parent lattice, fcc or bcc, for example,

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/456/download/... · 2017-01-11 · $1.2 $1.0 $0.8 $0.6 $0.4 $0.2 $0.0 DOZ £Z.Allergan OAKORN OMylan Glenmapk 27 ANDAS

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/456/download/... · 2017-01-11 · $1.2 $1.0 $0.8 $0.6 $0.4 $0.2 $0.0 DOZ £Z.Allergan OAKORN OMylan Glenmapk 27 ANDAS

29 OF SUCH JURISDICTION.filecache.investorroom.com/mr5ir_perrigo/251... · headline on Perrigo’s website at and on Elan’s website at . Also available on the companies’ websites

29 OF SUCH JURISDICTION.filecache.investorroom.com/mr5ir_perrigo/251... · headline on Perrigo’s website at and on Elan’s website at . Also available on the companies’ websites

Recapturing The Perrigo Advantagefilecache.investorroom.com/mr5ir_perrigo/612... · Rx-to-OTC Switches Base Business 2009 –2015 Consumer Americas adjusted revenue growth: ~$940M

Recapturing The Perrigo Advantagefilecache.investorroom.com/mr5ir_perrigo/612... · Rx-to-OTC Switches Base Business 2009 –2015 Consumer Americas adjusted revenue growth: ~$940M

Perrigo to Acquire Omega Pharma NV to Expand …filecache.investorroom.com › mr5ir_perrigo › 357 › download...Perrigo to Acquire Omega Pharma NV to Expand Leadership Position

Perrigo to Acquire Omega Pharma NV to Expand …filecache.investorroom.com › mr5ir_perrigo › 357 › download...Perrigo to Acquire Omega Pharma NV to Expand Leadership Position

Invest in repeatable growth platforms -Innovationfilecache.investorroom.com/mr5ir_perrigo/615... · Invest in repeatable growth platforms -Innovation Reconfigure the portfolio Achieve

Invest in repeatable growth platforms -Innovationfilecache.investorroom.com/mr5ir_perrigo/615... · Invest in repeatable growth platforms -Innovation Reconfigure the portfolio Achieve

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/422/download/160512_Q1 Earnings...Net sales growth of 2% on a constant currency basis excluding VMS** Strong demand

PowerPoint Presentationfilecache.investorroom.com/mr5ir_perrigo/422/download/160512_Q1 Earnings...Net sales growth of 2% on a constant currency basis excluding VMS** Strong demand